Marks and Spencer Group PLC (MKS)
London Exchange · UK · prices in GBX · close of 19 Oct 2026
Key indicators
| Last close | GBX 419.70 |
|---|---|
| 52-week range | 298.65 – 419.90 |
| Return, 1 month / 3 months | +18.1% / +5.4% |
| Return, 1 year / 3 years | +6.7% / +99.5% |
| Trend | Uptrend |
| RSI (14) | 71 |
| Volatility (1 year) | 30.1% |
| Worst drawdown (1 year) | -24.1% |
| Average daily value traded | 3,160.73M GBX |
| Dividend yield | 0.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Marks and Spencer Group is a British retailer based in London. It sells clothing for women, men and children, along with lingerie, homeware and furniture, largely under its own brands. Its food halls offer groceries, ready meals, wines and other food and drink, and the company also runs a substantial online shop alongside its stores. Customers are everyday shoppers in the United Kingdom and in its overseas markets, buying both fashion and food under one roof.
On this site Marks and Spencer Group PLC appears as a stock on the London Exchange (UK), code MKS, with prices in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Marks and Spencer Group PLC (MKS) trades on the London Exchange in UK. It last closed at GBX 419.70 on 19 October 2026.
Its price-based Market X-Ray is 66 out of 100 (a fair price profile), ranking 823 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 6.7% and over the last three months it rose 5.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 81 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 13.9% | ||
| From 52-week high | 0.0% | ||
| Momentum | 60 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 5.4% | ||
| 6-month return | 20.2% | ||
| 12-month return, skipping the last month | -9.6% | ||
| Stability (higher is calmer) | 62 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 30.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -24.1% | ||
| Liquidity | 99 · Strong | Trades actively. | |
| Average daily value traded | 3,160.73M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 6 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.0% | ||
| Years with dividends | 4 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +4.5% |
|---|---|
| 1 month | +18.1% |
| 3 months | +5.4% |
| 6 months | +20.2% |
| 1 year | +6.7% |
| 3 years | +99.5% |
| 5 years | +138.9% |
Signals
| 50-day / 200-day average | 386.30 / 368.59 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 10.76 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 4 Jun 2026 | GBP 0.0300 |
| 27 Nov 2025 | GBP 0.0120 |
| 29 May 2025 | GBP 0.0260 |
| 28 Nov 2024 | GBP 0.0100 |
| 30 May 2024 | GBP 0.0200 |
| 16 Nov 2023 | GBP 0.0100 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.